For decades, individuals undergoing in vitro fertilization (IVF) have utilized embryo scoring to screen for genetic disorders or chromosomal abnormalities, a practice widely accepted in reproductive medicine. This technology has provided crucial information to prospective parents, helping them make informed decisions about their reproductive health and the health of their future children.
However, the application of embryo scoring is rapidly evolving beyond disease screening. Startups are now offering services that claim to predict a future child's characteristics, such as intelligence, appearance, or specific behavioral traits. This development pushes the boundaries of medical ethics and societal norms, moving from preventing harm to potentially enhancing or selecting for specific attributes.
The expansion of embryo scoring into predicting non-medical traits raises significant ethical dilemmas, prompting debates about designer babies, social inequality, and the very definition of human value. These services present a complex challenge, as they could exacerbate existing social biases and create new forms of discrimination based on genetic predispositions.
Niall Firth highlighted embryo scoring as the most controversial technology on MIT Technology Review's list. He noted the profound difference between screening for genetic disorders and using the same technology to select for characteristics related to appearance, behavior, or intelligence, emphasizing that "that feels a little bit different."